Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > HRTX Heron Therapeutics > Detailed Quotes

HRTX Heron Therapeutics

3.860
-0.120-3.02%
Close 09/26 16:00 ET
3.8600.0000.00%
Post Mkt Price 09/26 16:30 ET
High
4.185
Open
3.950
Turnover
9.06M
Low
3.850
Pre Close
3.980
Volume
2.30M
Market Cap
472.64M
P/E(TTM)
Loss
52wk High
12.790
Shares
122.45M
P/E(Static)
Loss
52wk Low
2.190
Float Cap
313.60M
Bid/Ask %
0.00%
Historical High
830.000
Shs Float
81.24M
Volume Ratio
0.66
Historical Low
2.002
Dividend TTM
--
Div Yield TTM
95
P/B
-21.69
Dividend LFY
--
Div Yield LFY
2461.14%
Turnover Ratio
2.83%
Amplitude
8.42%
Avg Price
3.946
Lot Size
1
Float Cap
313.60M
Bid/Ask %
0.00%
Historical High
830.000
Shs Float
81.24M
Volume Ratio
0.66
Historical Low
2.002
Dividend TTM
--
P/B
-21.69
Dividend LFY
--
Turnover Ratio
2.83%
Amplitude
8.42%
Avg Price
3.946
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.
CEO: Dr. Barry D. Quart,Pharm.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...